home / stock / agn / agn news


AGN News and Press, Allergan plc From 06/05/19

Stock Information

Company Name: Allergan plc
Stock Symbol: AGN
Market: NYSE
Website: allergan.com

Menu

AGN AGN Quote AGN Short AGN News AGN Articles AGN Message Board
Get AGN Alerts

News, Short Squeeze, Breakout and More Instantly...

AGN - Evolus up 16% on strong Jeuveau ramp

Evolus ( EOLS +15.9% ) is up on 70% higher volume in reaction to the rapid enrollment in its Jeuveau Experience Treatment program. More than 3,000 provider accounts signed up in three weeks and 67% of patients switched from market leader BOTOX from Allergan ( AGN -1.9% ). Enrollment in...

AGN - Buy Allergan After Recent Dip

Fresh after the company rejected the idea of replacing its CEO, markets continue to send shares of Allergan ( AGN ) lower. At a recent price of $133, markets signal a lack of confidence in the company's future. The stock trades at a forward P/E of below 8 times, while the stock offers a di...

AGN - Goldman sees 17% upside in J&J in premarket analyst action

AbbVie (NYSE: ABBV ) resumed with Neutral rating and $84 (5% upside) price target at Goldman Sachs. More news on: AbbVie Inc., Allergan plc, Alder BioPharmaceuticals, Inc., Healthcare stocks news, Stocks on the move, , Read more ...

AGN - Allergan and Gedeon Richter Receive U.S. FDA Approval For Expanded Use of VRAYLAR® (cariprazine) in the Treatment of Bipolar Depression

DUBLIN and BUDAPEST, Hungary , May 28, 2019 /PRNewswire/ -- Allergan plc (NYSE: AGN) and Gedeon Richter Plc. today announced that the U.S. Food and Drug Administration (FDA) has approved a supplemental New Drug Application (sNDA) for VRAYLAR ® (cariprazine) for expanded ...

AGN - Adamas Pharmaceuticals: Was It Overrated?

I have been following Adamas Pharmaceuticals ( ADMS ) ever since they were able to receive FDA approval for their flagship product GOCOVRI for PD dyskinesia and OFF. Since then, I have started writing for Seeking Alpha and decided to write about my Adamas journey. Most of my writing has been f...

AGN - Walmart's 5260, Computex And Healthcare Headwinds (Stocks To Watch Podcast)

Our weekend preview of upcoming IPOs, earnings reports, conference presentations, investor days, IPO lockup expirations, FDA decisions, Barron's mentions and other key events that could impact stocks. If you are interested in listening to Stocks To Watch to start your Sunday (you can re...

AGN - Tracking David Tepper's Appaloosa Management Portfolio - Q1 2019 Update

This article is part of a series that provides an ongoing analysis of the changes made to David Tepper’s 13F portfolio on a quarterly basis. It is based on Appaloosa Management’s regulatory 13F Form filed on 05/15/2019. Please visit our Tracking David Tepper’s Appaloosa...

AGN - Stocks To Watch: Walmart's 5260, Computex And Healthcare Headwinds

Welcome to Seeking Alpha's Stocks to Watch - a preview of key events scheduled for the next week. Follow this account and turn the e-mail alert on to receive this article in your inbox every Saturday morning. No formal trade talks are scheduled between the U.S. and China, but President Trump...

AGN - Allergan Announces Updated Presentation Time at the Bernstein Strategic Decisions Conference

DUBLIN , May 24, 2019 /PRNewswire/ -- Allergan plc (NYSE: AGN) today announced that Chairman and CEO Brent Saunders will participate in a fireside chat at the Bernstein 35 th Annual Strategic Decisions Conference in New York, NY . The presentation will begin at 4:00 p.m. Eastern...

AGN - Tracking John Paulson's Paulson & Company Portfolio - Q1 2019 Update

This article is part of a series that provides an ongoing analysis of the changes made to John Paulson's 13F stock portfolio on a quarterly basis. It is based on Paulson's regulatory 13F Form filed on 05/15/2019. Please visit our Tracking John Paulson's Pau13lson & Company Portfolio ser...

Previous 10 Next 10